Past CureTalks
Alzheimer’s or Dementia. What’s the Difference?
Over 10 million people in the US have a neurodegenerative condition. Half of these people have Alzheimer's Disease making it the most common neurodegenerative condition in the US. Among the remaining, a large population suffer from frontotemporal dementia (FTD). However,…
Latest Advances in Myeloma Treatment: ASCO and EHA 2018 Highlights
The treatment field of Multiple Myeloma continues to move forward as novel agents and treatment combinations expand. Whether you are standard risk patient or belong to high-risk group, treatment paradigms are getting better. We are talking to Dr. Mateos on…
Reversing Blindness with New FDA Approved Retinal Gene Therapy
In December 2017, the FDA approved a DNA altering medication that can reverse an inherited form of progressive blindness. Luxturna is a gene therapy which can treat a condition called Leber's Congenital Amaurosis (LCA) wherein people have inherited two faulty…
Multiple Myeloma: An Insight into Early Intervention and Personalized Therapies
Myeloma patients are definitely living longer. A decade ago the median survival was 3 to 4 years, while now it is in the range of 8 to 10 years. With all the new drugs and treatments that have been approved,…
Effective Mind-Body Strategies to Reduce the Stress of Infertility and Improve Mental Health
Research has shown that our mental state affects the outcomes of treatment in all disease conditions, including infertility, where it may decrease the chances of conception. Couples dealing with infertility go through immense stress, often times severe depression, as the…